title: [Azelastine: evaluation of the protective effects in induced bronchospasm challenges].
authors.forename: C
authors.initials: C
authors.lastname: Marzo
authors.forename: A
authors.initials: A
authors.lastname: Cammarata
authors.forename: G
authors.initials: G
authors.lastname: Mazzarella
authors.forename: M
authors.initials: M
authors.lastname: Ciampini
authors.forename: F
authors.initials: F
authors.lastname: Bianchi
authors.forename: E
authors.initials: E
authors.lastname: Catena
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D001986:Bronchial Spasm / Q000209:etiology / Q000517:prevention & control*; D004311:Double-Blind Method; D004341:Drug Evaluation; D005260:Female; D006634:Histamine H1 Antagonists / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010793:Phthalazines / Q000627:therapeutic use*; D011724:Pyridazines / Q000627:therapeutic use*; D012129:Respiratory Function Tests
chemical_list: D006634:Histamine H1 Antagonists; D010793:Phthalazines; D011724:Pyridazines; C020976:azelastine
vernacular_title: Azelastina: valutazione degli effetti protettivi nei confronti del broncospasmo indotto.